+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

UAE Genetic Testing Market Size, Share & Trends Analysis Report by Technology (Next-generation Sequencing, Array Technology), by Application, by Channel, by End-use, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 97 Pages
  • July 2022
  • Region: United Arab Emirates
  • Grand View Research
  • ID: 5644987
The UAE genetic testing market size is expected to reach USD 120.82 million by 2030. The market is anticipated to expand at a CAGR of 22.2% from 2022 to 2030. The incidence of cancer is significant in the UAE, and it is the country's third-largest cause of noncommunicable diseases (NCD)-related mortality. According to WHO 2020 report, the UAE has a cancer incidence and mortality of 4,807 and 1,896, respectively. The UAE became one of the fastest-growing economies in the world in the mid-twentieth century, with this expansion contributing to economic, sociodemographic, and lifestyle changes in its population as well as an epidemiological increase in NCD rates. The increasing cases of cancer has is also estimated to drive the market growth.

The technological advancements in diagnostic equipment have proven to be very useful in preventing, maintaining, and treating genetic diseases. It has also proven to be beneficial in prompt intervention for treating diseases when detected early in infancy through newborn screening. Aside from providing precise and reliable estimates of the prevalence of inherited diseases, molecular genetic testing is playing a vital role in the understanding of genetic disease's molecular pathology. This analysis is expected to improve prognosis and guide the development of customized molecular diagnostic methodologies against gene-related diseases.

In June 2021, the UAE announced a new first-of-its-kind institution focused on strengthening local genomic research as well as detecting and treating people with genetic abnormalities. This aims to assist in achieving the objective of enhancing health through cutting-edge academic research and the development of future researchers who will serve individuals and organizations in the UAE and around the region. These factors are expected to boost the market growth during the forecast period.

Genetic research & development in the country is playing a vital role in the advancements of personalized medicines. Due to the wide range of applications offered by genetic testing, the authorities are focusing on conducting innovative programs for citizens. For instance, in March 2018, the Dubai authority announced its ambitious plan to test the DNAs of all three million citizens. Increasing support by the government and favorable regulatory policies is anticipated to boost the demand for gene-related testing in the country.

UAE Genetic Testing Market Report Highlights

  • By technology type, the next-generation sequencing segment held the highest market share of 46.4% in 2021 and is expected to witness the highest growth during the forecast period
  • The ancestry & ethnicity application segment held the highest share of the genetic testing market, owing to the significant decrease in the cost of tests. The adoption rate of these tests has increased hugely
  • Hospital segment captured the highest market share in 2021, owing to the increasing prevalence of hospitalization of patients with genetic disorders in the country. Congenital malformations is the second major cause of mortality in the UAE
  • By channel insights, the offline channel segment held the highest share in 2021 of the genetic testing market, owing to the integration of new molecular genetic testing technologies, allowing the genetic testing industry to expand at a rapid pace
  • Some of the key market players include Middle East Testing Services L.L.C, Molecular Biology & Genetics Laboratory, NSG, Freiburg Medical Laboratory Middle East, IVI MIDDLE EAST FERTILITY CLINIC, 23andMe, Inc, Ancestry, CircleDNA, 24Genetics

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Sample Size For The Study On Uae Genetic Testing Market:
1.3.1.1 Primary Sources:
1.3.1.2 Secondary Data Sources:
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Global Market: CAGR Calculation
1.7 Objectives
1.7.1 Objective 1:
1.7.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Summary
2.2 Market Segmentation
Chapter 3 Market Variables, Trends, And Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Increase In Incidences Of Genetic Disorders And Cancer
3.1.1.2 Rise In Awareness & Acceptance Of Personalized Medicines
3.1.1.3 Advancements In Genetic Testing Techniques
3.1.2 Market Restraint Analysis
3.1.2.1 Regulatory Requirements For Product Approvals
3.1.2.2 Dearth Of Trained Professionals
3.1.3 Market Opportunity Analysis
3.1.3.1 Increasing Application Of Genetic Testing In Oncology
3.1.3.2 Growing Adoption Of Pharmacogenetic Testing In Reducing Adverse Drug Events
3.1.3.3 Genetic Programs Initiated By Government To Encourage Genetic Testing
3.1.4 Market Challenge Analysis
3.1.4.1 Social And Ethical Implications Of Genetic Testing
3.2 Penetration and Growth Prospect Mapping
3.3 Factors Responsible for Exponential Market Growth in the Next 3-5 Years
3.4 Pricing Analysis
Chapter 4 Pharmacogenomics-Pgx Analysis
4.1 UAE Genetic Testing Market: Pharmacogenomics Analysis
4.1.1 Technology Used
4.1.2 Health Insurance Landscape For Genetic Counseling And Testing
4.1.3 Uae Genetic Testing Market Estimates And Forecast For Pharmacogenomics, 2019 - 2030 (USD Million)
Chapter 5 Technology Business Analysis
5.1 UAE Genetic Testing Market: Technology Movement Analysis
5.2 Next Generation Sequencing
5.2.1 UAE Genetic Testing Market Estimates And Forecast For NGS, 2019 - 2030 (USD Million)
5.2.2 Whole Exome Sequencing
5.2.2.1 UAE Genetic Testing Market Estimates And Forecast For Whole Exome Sequencing, 2019 - 2030 (USD Million)
5.2.3 Whole Genome Sequencing
5.2.3.1 UAE Genetic Testing Market Estimates And Forecast For Whole Genome Sequencing, 2019 - 2030 (USD Million)
5.3 Array Technology
5.3.1 Specific To Micro Array Technology
5.3.2 UAE Genetic Testing Market Estimates And Forecast For Array Technology, 2019 - 2030 (USD Million)
5.4 PCR-Based Testing
5.4.1 UAE Genetic Testing Market Estimates And Forecast For Pcr-Based Testing, 2019 - 2030 (USD Million)
5.5 FISH
5.5.1 UAE Genetic Testing Market Estimates And Forecast For Fish, 2019 - 2030 (USD Million)
5.6 Others
5.6.1 UAE Genetic Testing Market Estimates And Forecast For Other Technologies, 2019 - 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 UAE Genetic Testing Market: Application Movement Analysis
6.2 Ancestry & Ethnicity
6.2.1 UAE Genetic Testing Market Estimates And Forecast For Ancestry & Ethnicity, 2019 - 2030 (USD Million)
6.3 Cancer Screening
6.3.1 UAE Genetic Testing Market Estimates And Forecast For Cancer Screening, 2019 - 2030 (USD Million)
6.4 Genetic Disease Carrier Status
6.4.1 UAE Genetic Testing Market Estimates And Forecast For Genetic Disease Carrier Status, 2019 - 2030 (USD Million)
6.5 New Baby Screening
6.5.1 UAE Genetic Testing Market Estimates And Forecast For New Baby Screening, 2019 - 2030 (USD Million)
6.6 Traits
6.6.1 UAE Genetic Testing Market Estimates And Forecast For Traits, 2019 - 2030 (USD Million)
6.7 Health and Wellness - Predisposition/Risk/Tendency
6.7.1 UAE Genetic Testing Market Estimates And Forecast For Health And Wellness - Predisposition/Risk/Tendency, 2019 - 2030 (USD Million)
Chapter 7 End-Use Business Analysis
7.1 UAE Genetic Testing Market: End-use Movement Analysis
7.2 Hospitals & Clinics
7.2.1 UAE Genetic Testing Market For Hospitals & Clinics, 2019 - 2030 (USD Million)
7.3 Diagnostic Laboratories
7.3.1 UAE Genetic Testing Market For Diagnostic Laboratories, 2019 - 2030 (USD Million)
7.4 Others
7.4.1 UAE Genetic Testing Market For Other End-Users, 2019 - 2030 (USD Million)
Chapter 8 Channel Business Analysis
8.1 UAE Genetic Testing Market: Channel Movement Analysis
8.2 Online (Own Website/ App, Aggregators, Market Place)
8.2.1 UAE Genetic Testing Market For Online Channel, 2019 - 2030 (USD Million)
8.3 Offline (Pharmacy, Own Clinics, partner clinics, Lab, Hospitals)
8.3.1 UAE Genetic Testing Market For Offline Channel, 2019 - 2030 (USD Million)
8.4 Others
8.4.1 Uae Genetic Testing Market For Other Channels, 2019 - 2030 (Usd Million)
Chapter 9 Competitive Landscape
9.1 Company Categorization
9.2 Vendor Landscape
9.2.1 List Of Key Distributors And Channel Partners
9.2.2 Key Customers
9.2.2.1 List of key customers
9.2.3 Public Companies
9.2.3.1 List of public companies
9.2.4 Private Companies
9.2.4.1 List of key private companies
9.2.5 Emerging Players
9.2.5.1 List of key emerging companies
9.3 Recent Developments and Impact Analysis by Key Market Participants
9.3.1.1 Key success factors
9.4 Market Share Analysis by Key Players - 2021
9.5 Company Profiles
9.5.1 MIDDLE EAST TESTING SERVICES L.L.C
9.5.1.1 Company overview
9.5.1.2 Product benchmarking
9.5.2 MOLECULAR BIOLOGY & GENETICS LABORATORY
9.5.2.1 Company overview
9.5.2.2 Product benchmarking
9.5.3 NSG
9.5.3.1 Company overview
9.5.3.2 Product benchmarking
9.5.4 FREIBURG MEDICAL LABORATORY MIDDLE EAST (L.L.C)
9.5.4.1 Company overview
9.5.4.2 Product benchmarking
9.5.5 IVI MIDDLE EAST FERTILITY CLINIC
9.5.5.1 Company overview
9.5.5.2 Product benchmarking
9.5.6 23ANDME, INC.
9.5.6.1 Company overview
9.5.6.2 Financial performance
9.5.6.3 Product benchmarking
9.5.6.4 strategic initiatives
9.5.7 ANCESTRY
9.5.7.1 Company overview
9.5.7.2 Product benchmarking
9.5.8 CIRCLEDNA
9.5.8.1 Company overview
9.5.8.2 Product benchmarking
9.5.9 24GENETICS
9.5.9.1 Company overview
9.5.9.2 Product benchmarking
9.5.10 MYDNA LIFE AUSTRALIA PTY LTD.
9.5.10.1 Company overview
9.5.10.2 Product benchmarking
9.5.11 BEYOND NUTRITION HEALTH AND WELLNESS SERVICES DMCC
9.5.11.1 Product benchmarking
List of Tables
Table 1 The most common primary malignant tumors in UAE for both genders, 2017
Table 2 Pricing analysis
Table 3 The comparison of at-home kits
Table 4 List of key distributors and channel partners
Table 5 UAE genetic testing market, by technology, 2019-2030 (USD Million)
Table 6 UAE genetic testing market, by application, 2019-2030 (USD Million)
Table 7 UAE genetic testing market, by end-use, 2019-2030 (USD Million)
Table 8 UAE genetic testing market, by channel, 2019-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Direct-to-consumer genetic testing market snapshot, 2021 (USD Million)
Fig. 9 UAE genetic testing market segmentation
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Penetration and growth prospect mapping
Fig. 14 UAE genetic testing market estimates and forecast for pharmacogenomics, 2019-2030 (USD Million)
Fig. 15 UAE genetic testing market: Technology outlook and key takeaways
Fig. 16 UAE genetic testing market: Technology movement analysis
Fig. 17 UAE genetic testing market estimates and forecast for NGS, 2019-2030 (USD Million)
Fig. 18 UAE genetic testing market estimates and forecast for whole exome sequencing, 2019-2030 (USD Million)
Fig. 19 UAE genetic testing market estimates and forecast for whole genome sequencing, 2019-2030 (USD Million)
Fig. 20 UAE genetic testing market estimates and forecast for array technology, 2019-2030 (USD Million)
Fig. 21 UAE genetic testing market estimates and forecast for PCR-based testing, 2019-2030 (USD Million)
Fig. 22 UAE genetic testing market estimates and forecast for FISH, 2019-2030 (USD Million)
Fig. 23 UAE genetic testing market estimates and forecast for other technologies, 2019-2030 (USD Million)
Fig. 24 UAE genetic testing market: Application outlook and key takeaways
Fig. 25 UAE genetic testing market: Application movement analysis
Fig. 26 UAE genetic testing market estimates and forecast for ancestry & ethnicity, 2019-2030 (USD Million)
Fig. 27 UAE genetic testing market estimates and forecast for cancer screening, 2019-2030 (USD Million)
Fig. 28 UAE genetic testing market estimates and forecast for genetic disease carrier status, 2019-2030 (USD Million)
Fig. 29 UAE genetic testing market estimates and forecast for new baby screening, 2019-2030 (USD Million)
Fig. 30 UAE genetic testing market estimates and forecast for traits, 2019-2030 (USD Million)
Fig. 31 UAE genetic testing market estimates and forecast for health and wellness-predisposition risk/tendency, 2019-2030 (USD Million)
Fig. 32 UAE genetic testing market: End-use outlook and key takeaways
Fig. 33 UAE genetic testing market: End-use movement analysis
Fig. 34 UAE genetic testing market for hospitals & clinics, 2019-2030 (USD Million)
Fig. 35 UAE genetic testing market for diagnostic laboratories, 2019-2030 (USD Million)
Fig. 36 UAE genetic testing market for other end-users, 2019-2030 (USD Million)
Fig. 37 UAE genetic testing market: Channel outlook and key takeaways
Fig. 38 UAE genetic testing market: Channel movement analysis
Fig. 39 UAE genetic testing market for online channel, 2019-2030 (USD Million)
Fig. 40 UAE genetic testing market for offline channel, 2019-2030 (USD Million)
Fig. 41 UAE genetic testing market for other channels, 2019-2030 (USD Million)
Fig. 42 Company categorization-UAE genetic testing market
Fig. 43 Company market share analysis: Instruments

Companies Mentioned

  • MIDDLE EAST TESTING SERVICES L.L.C
  • MOLECULAR BIOLOGY & GENETICS LABORATORY
  • NSG
  • FREIBURG MEDICAL LABORATORY MIDDLE EAST (L.L.C)
  • IVI MIDDLE EAST FERTILITY CLINIC
  • 23ANDME, INC.
  • ANCESTRY
  • CIRCLEDNA
  • 24GENETICS
  • MYDNA LIFE AUSTRALIA PTY LTD.
  • BEYOND NUTRITION HEALTH AND WELLNESS SERVICES DMCC

Methodology

Loading
LOADING...

Table Information